Siegfried Muhlack

Impact of Gastric Emptying on Levodopa Pharmacokinetics in Parkinson Disease Patients

Thomas M ller, C. Coronado Erdmann, Dirk Bremen et al. · Clinical Neuropharmacology · 2006 · 128 citations

Levodopa Pharmacokinetics, Medicine, Parkinson Disease +9

Exercise improves efficacy of levodopa in patients with Parkinson's disease

Siegfried Muhlack, Jacub Welnic, Dirk Woitalla et al. · Movement Disorders · 2007 · 66 citations

Inhibition of catechol‐<i>O</i>‐methyltransferase contributes to more stable levodopa plasma levels

Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack et al. · Movement Disorders · 2005 · 54 citations

Plasma Half-life, Molecular Pharmacology, Biochemistry +14

Differential executive control impairments in early Parkinson’s disease

J. Uekermann, Irene Daum, M. Bielawski et al. · Journal of neural transmission. Supplementum · 2004 · 53 citations

Neurodegenerative Diseases, Neurological Functioning, Early Parkinson ’ +5

Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel

Thomas Müller, Constanze Jugel, Reinhard Ehret et al. · Journal of Neural Transmission · 2011 · 52 citations

Duodenal Levodopa/carbidopa Gel, Neurodegenerative Diseases, Medicine +5